Navi Technologies

India

$1B

$582M

Gaja Capital

Central vascular access devices (CVADs) in newborns and children have high misplacement rates, exceeding 40% of Umbilical Venous Catheters (UVCs) and 37% of Peripherally Inserted Central Catheters (PICCs) at time of insertion. Misplacement may lead to repeated insertions, additional imaging for catheter tip verification, and delays in initiating therapy for critically ill patients.